June 4 @ 1:30 pm – 2:30 pm New York
Live Virtual Event
Patience, Patients and Persistent Antimicrobial Resistance
Prof. Colm Dunne, University of Limerick, Ireland
Free
Teleclass
Live broadcast time:
1:30pm-2:30pm in New York / Toronto
7:30pm in Geneva
3:30am (June 5) in Sydney
2:30pm in Buenos Aires
8:30pm in Riyadh
17:30 UTC
Objectives
- Antimicrobial Resistance (AMR) has been an acknowledged risk for decades. However, despite interventions and promotion of antimicrobial stewardship incidence of resistance and outbreaks of drug-resistant bacteria and fungi are increasing, although the species involved are no longer necessarily dominated by those familiar to us. It is now evident that progress in this area of healthcare is slow and will require resilience in education and training.
- Frequently, strategies to prevent or mitigate AMR state that patients are central to the process. Despite this, they remain most affected by outbreaks and hospital infections. In certain cases, patients can present with colonisation or infection that is challenging to characterise and treat. In such cases, innovations in molecular analysis can provide the information needed, sometimes with useful TAT, to ensure positive outcomes for the patients. However, sometimes knowing the microbes involved does not mean that cases are unambiguous and that clinical decisions are straightforward, especially when novel species are detected.
- AMR is not restricted to hospitals, or even to human medicine. The OneHealth initiative acknowledges this, and is a useful lens through which to evaluate microbial resistance in the environment and especially the implications of antibiotic use in veterinary medicine.